Photon Biosciences

Photon Biosciences is an early-stage diagnostics company building a portable, multi-application testing platform called PBSDx. The platform combines proprietary imaging technology with AI and optics to deliver rapid, accurate results for human and veterinary health. Its initial pipeline focuses on heart failure prediction, bacterial contamination in blood platelets, and companion animal diagnostics, targeting the critical need for decentralized, point-of-solution testing. The company appears to be privately held, pre-revenue, and in the development stage of its first-generation platform and test portfolio.

PBSDx platform integrating proprietary biological imaging molecules (PBS), AI/machine learning algorithms, and advanced optics to enable portable, lab-quality multiplex diagnostics.

Competes in the crowded point-of-care diagnostics space against large, established players (e.g., Abbott, Roche) and numerous startups. Must differentiate by demonstrating superior multiplex capability, predictive analytics, and portability without sacrificing the accuracy of central lab tests.